Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.

Caritis SN, Rouse DJ, Peaceman AM, Sciscione A, Momirova V, Spong CY, Iams JD, Wapner RJ, Varner M, Carpenter M, Lo J, Thorp J, Mercer BM, Sorokin Y, Harper M, Ramin S, Anderson G; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Maternal-Fetal Medicine Units Network (MFMU).

Obstet Gynecol. 2009 Feb;113(2 Pt 1):285-92. doi: 10.1097/AOG.0b013e318193c677.

2.

A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.

Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, Varner M, Malone F, Iams JD, Mercer BM, Thorp J, Sorokin Y, Carpenter M, Lo J, Ramin S, Harper M, Anderson G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

N Engl J Med. 2007 Aug 2;357(5):454-61.

3.

Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.

Manuck TA, Stoddard GJ, Fry RC, Esplin MS, Varner MW.

Am J Obstet Gynecol. 2016 Nov;215(5):622.e1-622.e8. doi: 10.1016/j.ajog.2016.07.013. Epub 2016 Jul 11.

PMID:
27418444
4.

17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.

Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJ, van Eyck J, Groenwold RH, Hasaart TH, Hummel P, Kars MM, Kwee A, van Oirschot CM, van Pampus MG, Papatsonis D, Porath MM, Spaanderman ME, Willekes C, Wilpshaar J, Mol BW, Bruinse HW.

Obstet Gynecol. 2011 Sep;118(3):513-20. doi: 10.1097/AOG.0b013e31822ad6aa.

PMID:
21860279
5.

Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.

Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR).

Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.

6.

A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.

Awwad J, Usta IM, Ghazeeri G, Yacoub N, Succar J, Hayek S, Saasouh W, Nassar AH.

BJOG. 2015 Jan;122(1):71-9. doi: 10.1111/1471-0528.13031. Epub 2014 Aug 27.

7.

17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.

Combs CA, Garite TJ, Maurel K, Abril D, Das A, Clewell W, Heyborne K, How H, Huang W, Lewis D, Lu G, Miller H, Nageotte M, Porreco R, Sheikh A, Tran L; Obstetrix Collaborative Research Network.

Am J Obstet Gynecol. 2015 Sep;213(3):364.e1-12. doi: 10.1016/j.ajog.2015.05.009. Epub 2015 May 13.

PMID:
25979614
8.

17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.

Winer N, Bretelle F, Senat MV, Bohec C, Deruelle P, Perrotin F, Connan L, Vayssière C, Langer B, Capelle M, Azimi S, Porcher R, Rozenberg P; Groupe de Recherche en Obstétrique et Gynécologie.

Am J Obstet Gynecol. 2015 Apr;212(4):485.e1-485.e10. doi: 10.1016/j.ajog.2014.10.1097. Epub 2014 Oct 30.

PMID:
25448515
9.

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial.

Harper M, Thom E, Klebanoff MA, Thorp J Jr, Sorokin Y, Varner MW, Wapner RJ, Caritis SN, Iams JD, Carpenter MW, Peaceman AM, Mercer BM, Sciscione A, Rouse DJ, Ramin SM, Anderson GD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Obstet Gynecol. 2010 Feb;115(2 Pt 1):234-42. doi: 10.1097/AOG.0b013e3181cbd60e.

10.

Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.

Caritis SN, Venkataramanan R, Thom E, Harper M, Klebanoff MA, Sorokin Y, Thorp JM Jr, Varner MW, Wapner RJ, Iams JD, Carpenter MW, Grobman WA, Mercer BM, Sciscione A, Rouse DJ, Ramin S; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network and Obstetric-Fetal Pharmacology Research Units Network.

Am J Obstet Gynecol. 2014 Feb;210(2):128.e1-6. doi: 10.1016/j.ajog.2013.10.008. Epub 2013 Oct 7.

11.

A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.

Elimian A, Smith K, Williams M, Knudtson E, Goodman JR, Escobedo MB.

Int J Gynaecol Obstet. 2016 Aug;134(2):169-72. doi: 10.1016/j.ijgo.2016.01.010. Epub 2016 Apr 18.

PMID:
27168167
12.

Progesterone does not prevent preterm births in women with twins.

Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, Morrison JC.

South Med J. 2009 Sep;102(9):900-4. doi: 10.1097/SMJ.0b013e3181afee12.

PMID:
19668021
13.

Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.

O'Brien JM, Lewis DF.

Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Epub 2015 Nov 10. Review.

PMID:
26558340
14.

Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.

Mainiero AD, Rouse DJ, Lopes V, Hughes BL.

Obstet Gynecol. 2015 Jul;126(1):103-8. doi: 10.1097/AOG.0000000000000881.

PMID:
26241262
15.

Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial.

Lim AC, Bloemenkamp KW, Boer K, Duvekot JJ, Erwich JJ, Hasaart TH, Hummel P, Mol BW, Offermans JP, van Oirschot CM, Santema JG, Scheepers HC, Schöls WA, Vandenbussche FP, Wouters MG, Bruinse HW; AMPHIA study group.

BMC Pregnancy Childbirth. 2007 Jun 19;7:7.

16.

Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-α hydroxyprogesterone caproate.

Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Varner MW, Malone FD, Mercer BM, Thorp JM Jr, Sorokin Y, Carpenter MW, Lo J, Ramin SM, Harper M, Spong CY; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

J Matern Fetal Neonatal Med. 2010 Dec;23(12):1360-4. doi: 10.3109/14767051003702786. Epub 2010 May 4.

17.

17 α-Hydroxyprogesterone caproate (Makena™): in the prevention of preterm birth.

Deeks ED.

Paediatr Drugs. 2011 Oct 1;13(5):337-45. doi: 10.2165/11208140-000000000-00000. Review.

PMID:
21888448
18.

The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.

Gyamfi C, Horton AL, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Meis PJ, Spong CY, Dombrowski M, Sibai B, Varner MW, Iams JD, Mercer BM, Carpenter MW, Lo J, Ramin SM, O'Sullivan MJ, Miodovnik M, Conway D; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Am J Obstet Gynecol. 2009 Oct;201(4):392.e1-5. doi: 10.1016/j.ajog.2009.06.036. Epub 2009 Aug 29.

19.

Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.

Ning A, Vladutiu CJ, Dotters-Katz SK, Goodnight WH, Manuck TA.

Am J Obstet Gynecol. 2017 May 17. pii: S0002-9378(17)30631-2. doi: 10.1016/j.ajog.2017.05.022. [Epub ahead of print]

PMID:
28526452
20.

17-Hydroxyprogesterone caproate (17OHP-C) coverage among eligible women delivering at 2 North Carolina hospitals in 2012 and 2013: A retrospective cohort study.

Stringer EM, Vladutiu CJ, Manuck T, Verbiest S, Ollendorff A, Stringer JS, Menard MK.

Am J Obstet Gynecol. 2016 Jul;215(1):105.e1-105.e12. doi: 10.1016/j.ajog.2016.01.180. Epub 2016 Jan 29.

PMID:
26829508

Supplemental Content

Support Center